2 insiders reported 5 Form 4 transactions for ProQR Therapeutics N.V. (PRQR) over the past 18 months (most recent 2026-08-03). Recent activity: de Boer Daniel Anton (Chief Executive Officer) Buy 200,000 shares, Filius Bart (Director) Buy 150,000 shares, de Boer Daniel Anton (Chief Executive Officer) Buy 150,000 shares, de Boer Daniel Anton (Chief Executive Officer) Buy 150,000 shares, Filius Bart (Director) Buy 150,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-03 | de Boer Daniel Anton | Chief Executive Officer | Buy | 200,000 | $353,960 |
| 2026-07-21 | Filius Bart | Director | Buy | 150,000 | $257,925 |
| 2026-07-13 | de Boer Daniel Anton | Chief Executive Officer | Buy | 150,000 | $261,000 |
| 2026-07-08 | de Boer Daniel Anton | Chief Executive Officer | Buy | 150,000 | $238,500 |
| 2026-06-30 | Filius Bart | Director | Buy | 150,000 | $231,000 |
Source: SEC Form 4 filings · as of 2026-08-03